Transfusion-transmitted Chagas' disease

Current Opinion in Hematology

Volumn 5, Issue 6, 1998, Pages 406-411

  Wendel, Silvano ^a  

^a NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET;

BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; CLINICAL FEATURE; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCREENING; TRYPANOSOMA CRUZI;

EID: 0031774163     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199811000-00009     Document Type: Review

References (79)

1. Chagas C: Neue Trypanosomen. Arch Schiffs Tropenhyg 1909, 13:120-122. Initial description in a non-Brazilian medical journal about this new parasite, with historical interest.
2. Chagas C: Über eine neue Trypanosomiasis des Menschen. Arch Schiffs Tropenhyg 1909, 13:351-353.
3. Mazza S, Montana A, Benitez C, Juzin E: Transmisión de "Schizotrypanum cruzi" al niño por leche de la madre con enfermedad de Chagas. MEPRA 1936, 28:41-46.
4. Freitas JLP, Amato V, Sonntag R, Biancalana A, Nussenszweig V, Barreto JG: Primeiras verificacões de transmissão acidental da molestia de Chagas ao homem por transfusão de sangue. Rev Paul Med 1952, 40:36-40.
5. Geiseler PJ, Ito, JL, Tegtemeier BR, Kemdt PR, Krance R: Fulminant Chagas' disease in bone marrow transplantation [abstract]. 27th Intersc Conf on Antimicro Agents and Chemoter 1987. Washington: Am Soc for Microbiol; 1987:418.
6. Grant I, Gold JWH, Wittnee M, et al: Transfusion associated acute Chagas disease acquired in the United States. Ann Intern Med 1989, 111:849-851.
7. Nickerson P, Orr P, Schoeder MC, Sekla L, Johnson J: Transfusion associated Trypanosoma cruzi infection in a non endemic area. Ann Intern Med 1989, 111:851-853.
8. Cimo PL, Luper WE, Scouros MA: Transfusion-associated Chagas disease in Texas: report of a case. Tex Med 1993, 89:48-50.
9. Leiby DA, Yund J, Read EJ, Lenes BA, Dodd RY: Risk factors for Trypanosoma cruzi infection in seropositive blood donors. Transfusion 1996, 36:(suppl 9S):S228.
10. Galel S, Wolles S, Stumpf R: Evaluation of a selective donor testing strategy. Transfusion 1997, 37(suppl 9S):S297.
11. Leiby DA, Jensen NC, Fucci MC, Stumpf RJ: Prevalence of Trypanosoma cruzi antibodies in a Wood donor population at low risk. Transfusion 1997, 37(suppl 9S):S297. A good report about the existence of Trypanosoma cruzi-infected donors in low-risk areas from the USA, including the existence of infection in members of three generations within the same family.
12. Schmunis GA: American trypanosomiasis as a public health problem, in Pan American Health Organization: Chagas' disease and the nervous system. Washington: Scientific Publication no. 547:3-29; 1994.
13. Hayes RJ, Schofield CJ: Estimación de las tasas de incidencia de infecciones y parasitosis crónicas a partir de la prevalencia: la enfermedad de Chagas en America Latina. Bol of Sanit Panam 1990, 108:308-316.
14. Moncayo A: Chagas' disease. Tropical disesase research. Progress 1991-92. Eleventh Programme Report of the United Nations Developing Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization, 1993:67-75.
15. Chocair PR, Sabbaga E, Amato Net V, Shiroma M, Goes GM: Transplante de rim: nova modadlidade de transmissaõ da doença de Chagas. Rev Inst Med Trop Sao Paulo 1981, 23:282.
16. Ferraz AS, Figueiredo JFC: Transmission of Chagas' disease thorugh transplanted kidney: ocurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop São Paulo 1993, 35:461-463.
17. Wendel S, Brener Z, Camargo M, Rassi A, eds: Chagas' disease (American trypanosomiasis): its impact on transfusion and clinical medicine. ISBT, Sociedade Brasileira de Hematologia e Hemoterapia, Brasil 1992.
18. Dias JCP, Brener Z: Chagas' disease and blood transfusion. Mem Inst Oswaldo Cruz 1984, 79:139-147.
19. Schmunis GA: Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991, 31:547-557.
20. Wendel S, Gonzaga AL: Chagas disease and blood transfusion: a new world problem? Vox Sang 1993, 64:1-12.
21. Schmunis GA: Tripanosomiase Américana: seu impacto nas Américas e perspectivas de eliminação. In Clinica e terapeutica da doença de Chagas. Edited by Dias JCP, Coura JR. Rio de Janeiro: Edotora Fiocruz; 1997:11-23.
22. Wendel S: Doença de Chagas Transfusional. In Clinica e terapeutica da doença de Chagas. Edited by Dias JCP, Coura JR. Edotora Fiocruz; 1997:411-427.
23. Wendel S, Neitzert E, Lopes VHG, Batemarchi MV: Evaluation of different screening tests for T. cruzi antibodies and correlation with immunoblotting technique [abstract TTD-17]. Rev Paul Med 1992, 110.
24. Kerndt PR, Waskin HA, Kirhhoff LV, Steurer F, Waterman SH, Nelson JM, Gellert GA, Shulman IA: Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991, 31:814-818.
25. Pan AA, Brashear J, Schur JD, Winkler MA, Hall H, Shih J, Decker R: Prevalence sutdy and confirmation of seropositive antibodies to Trypanosoma cruzi (Chagas' disease) in Hispanic and non-Hispanic blood donors in the United States [abstract TTD-18]. Rev Paul Med 1992, 110(suppl 5).
26. Read EJ, Leiby DA, Dodd RY: Seroprevalence of Trypanosoma cruzi (T. cruzi) in blood donors with and without risk infection [abstract 1853]. Blood 1994, 84(suppl 1).
27. Amato Neto V, Leonhardt H, Souza HBWT: Liofilização do plasma: medida capaz de evitar a transmissão da Doença de Chagas em Bancos de Sangue. Rev Inst Med Trop São Paulo 1966, 8:122-124.
28. Sullivan TS: Viability of Trypanosoma cruzi in citrated blood stored at room temperature. J Parasitol 1944, 30:200.
29. Weinman D; MacAlister J: Prolonged storage of human pathogenic protozoa with conservation of virulence. Am J Hyg 1947, 45:102-121.
30. Filardi LS, Brener Z: Cryopreservation of Trypanosoma cruzi bloodstream forms. J Protozool 1975, 22:398-401.
31. Schlemper BR Jr: Estudos experimentais de quimioprofilaxia de transmissão da doença de Chagas por transfusão sangüínea. Rev Pathol Trop 1978, 7:55-111.
32. Cerisola JA, Rabinovich A, Alvarez M, Di Corleho CA, Pruneda J: Enfermedad de Chagas y la transfusion de sangre. Bol of Sanit Panam 1972, 63:203-221.
33. Lorca M, Lorca J, Child R, Alias A, Conales M, et al.: Prevalencia de la infección por Trypanosoma cruzi en pacientes politransfundidos. Rev Med Chil 1988, 116:112-116.
34. Villalba R, Fornés G, Alvarez MA, Román V, Fernandez M, Garcia JM, Viñals M, Torres A: Acute Chagas' disease in a recipient of a bone marrow transplant in Spain [case report]. Clin Infect Dis 1992, 14:594-595.
35. Kirchhoff LV, Neva FA: Chagas' disease in Latin American immigrants. JAMA 1985, 254:3058-3060.
36. Kirchhoff LV: Trypanosoma cruzi: a new threat to our blood transfusion supply [editorial]. Ann Intern Med 1989, 111:773-775.
37. Kirchhoff LV: American trypanosomiasis (Chagas' disease): a tropical disease now in the United States. N Engl J Med 1993, 329:639-644.
38. Milei J, Mautner B, Storino R, Sanchez JÁ, Ferraris VS: Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States [editorial]? Am Heart J 1992, 123:1732-1735.
39. Andrade ALLS, Martelli CMT, Loquetti AO, Oliveira OS, Silva AS, Zicker F: Triagen sorológica para o Trypanosoma cruzi entre doadores de sangue do Brasil central. Bol of Sanit Panam 1992, 113:19-27.
40. World Health Organization: Parasite antigens. Bull World Health Organization 1975, 52: 237-249.
41. World Health Organization Report Newsletter 1982, 18:7.
42. Cura E, Wendel S, eds: Manual de procedimientos de control de calidad para los laboratories de serologia de los bancos de sangre. Washington: Pan American Health Organization/HPC/HPT/1994. [94:21].
43. Takei K: Estudo da eficiência relativa dos diferentes testes serológicos utilizados no diagnóstico da doença de Chagas: resultados observados na análise de 10.181 soros [PhD thesis]. São Paulo: Universidade de São Paulo; 1982.
44. Wendel S, Siqueira RV, Lopes VHG, Batemarchi MV, Neitzert E, Antunes MF, Mejias S: Assessing the performance of Trypanosoma cruzi antibody detection currently in use in Brazilian blood centres: a few answers from a large prevalence study [abstract]. Rev Paul Med 1992, 110(5).
45. Nukui Y, Kutner JM, Roberti MRF, Saéz-Alquézar A, Correa NS, Dorlhiac-Llacer PE, Chamone DAF: Prevalence of Chagas' disease in multitransfused patients [abstract]. Transfusion 1992, 32(suppl S160):42S.
46. Wendel S: Blood banking: preventive approaches for Chagas' disease. Mem Inst Oswaldo Cruz 1993, 88(suppl):59-60.
47. Martelli CMT, Andrade ALSS, Silva AS, Zicker F: Risk factor for Trypanosoma cruzi infection among blood donors in central Brazil. Mem Inst Oswaldo Cruz 1992, 87:339-343.
48. Zicker F, Martelli CMT, Andrade ALLS, Silva AS: Trends of T. cruzi infection based on data from blood bank screening. Rev Inst Med Trop São Paulo 1990, 39:132-137.
49. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV: Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion 1993, 33:61-64.
50. Leiby DA, Read EJ, Lenes BA, Yund AJ, Sumpf RJ, Kirchhoff LV, Dodd RY: Seroepidemiology of Trypanosoma cruzi, etiololgic agent of Chagas' disease, in US blood donors. J Infect Dis 1997, 176:1047-1052. A prevalence study covering several thousand US blood donors from different regions.
51. Wendel S, Biagini S: Absence of serological surrogate markers for Trypanosoma cruzi infected blood donors. Vox Sang 1995, 69:44-49.
52. Nussenzweig V, Sonntag R, Biancalana A, Freitas JLP, Amato Neto V, et al.: Ação de corantes tri-fenil-metanicos sobre o Trypanosoma cruzi "in vitro": emprego da Violeta de Genciana na profilaxia da transmissão da moléstia de Chagas por transfusão de sangue. O Hospital 1953, 44:731-744.
53. Docampo R, Moreno SNJ, Muniz RP, Cruz FS, Mason RP: Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet). Science 1983, 220:1292-1295.
54. Docampo R, Moreno SNJ: Free radicals metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Ver Infect Dis 1984, 6:223-238.
55. Docampo R, Gadelha FR, Moreno SNJ, Benaim E, Hoffman ME, Vercasi ARE: Disruption of Ca+2 homeostasis in Trypanosoma cruzi by crystal violet. J Eur Microbiol 1993, 40:311-316.
56. Docampo R, Moreno SNJ, Cruz F: Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate. Mol Biochem Parasitol 1988, 27:241-248.
57. Souza HM: The present state of chemoprophylaxis in transfusional Chagas' disease [editorial]. Rev Soc Bras Med Trop 1989, 22:1-3.
58. Ramirez LE, Lages-Silva E, Painetti GM, Rabello RMC, Bordin JO, Souza HM: Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Transfusion 1995, 35:226-230.
59. Gottlieb P, Shen LG, Chimezie E, Bahng S, Keeney ME, Horowitz B, Bem-Hur E: Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines. Photochem Photobiol 1995, 62:869-874.
60. Wendel S, Takaoka DT, Fachini R, Oliveira LC, Lima LP, Tibbals MA, Leiby DA: Serological screening tests for Trypanosoma cruzi antibodies: the role of supplemental methods. Transfusion 1997, 27(suppl):S298. A correlation study demonstrating a strong association between Trypanosoma cruzi titers (by immunofluorescent assay test, the likelihood of parasitemia and positive reactions with other still unlicensed tests [western blot and radioimmunoprecipitation assay]).
61. Moser DR, Kirchhoff LV, Donelson JE: Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol 1989, 27:1477-1482.
62. Britto C, Cardoso MA, Wincker P, Morel CM: A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in the porymerase chain reaction (PCR)-based diagnosis of chronic chages disease. Mem Inst Oswaldo Cruz, 1993, 88:171-172.
63. Kirchhoff LV, Votava JR, Ochs DE, Moser DR: Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J Clin Microbiol 1996, 34:1171-1175.
64. Souto RP, Zingales B: Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. Mol Biochem Parasitol 1993, 62:45-52.
65. Lal RB, Ottesen EA: Phosphocoline epitopes on helminth and protozoal parasites and their presence in the circulation of infected human patients. Trans R Soc Trop Med Hyg 1989, 83:652-655.
66. Ferreira AW: Serological diagnosis: tests for Chagas' disease serodiagnosis. A review. In Chagas' disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. Edited by Wendel S, Brener Z, Camarto ME, Rassi A, São Paulo: ISBT; 1992:179-193.
67. Luquetti AO: Use of Trypanosoma cruzi-defined proteins for diagnosis: multicentre tiral, serological and technical aspects. Mem Inst Oswaldo Cruz 1990, 85:497-505.
68. Zicker F, Smith PG, Luquetti AO, Oliveira OS: Mass screening for Trypanosoma cruzi infections using the immunofluorescence, enzyme linked immunosorbent assay and hemagglutination tests on serum samples and on blood eluates from filter paper. Bull World Health Organization 1990, 68:465-471.
69. Andrade ALSS, Martelli CMT, Luquetti AO, Oliveira OS, Silva SA, Zicker F: Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. Bull Pan Am Health Organ 1992, 26:157-164.
70. Fife EH Jr., Mushel HL: Fluorescent antibody technique for serodiagnosis of Trypanosoma cruzi infection. Proc Soc Exp Biol 1959, 101:540-543.
71. Camargo ME, Souza SL: The use of filter paper blood smears in a practical fluorescent test for American trypanosomiasis serodiagnosis. Rev Inst Med Trop São Paulo 1966, 8:255-258.
72. Velasquez L, Reyes L, Thors C, Miettinen A, Chinchella M, Linder E: Autoantibodies give false positive reactions in the serodiagnosis of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1993, 887:35.
73. Lanar DE, Manning JE: Major surface proteins and antigens on the different in vivo and in vitro forms of Trypanosoma cruzi. Mol Biochem Parasitol 1994, 11:119-131.
74. Rosfjord EC, Mikhael KS, Rowland EC, Powell MR: Analysis of antibody cross-reactivity in experimental American trypanosomiasis. J Parasitol 1990, 76:698-702.
75. Sabino EC, Salles N, Stoops E, Santos ML, Saez-Alquezar A: Evaluation of Chagas innolia assay as a confirmatory test for Chagas' disease. Mem Inst Oswaldo Cruz 1997, 92(suppl 1):266.
76. Costa GCV, Teixeira MGM, Borges-Pereira J, Castro JAF, Coura JR, Vanderborght BOM, Stroops E, Zrein M, Peralta JM, Oelemann WMR: A recombinant antigen and peptide line immunoassay (LIA) as an alternative diagnostic test for Chagas' disease. Mem Inst Oswaldo Cruz 1997, 92(suppl 1):267.
77. Kihchhoff LV, Gam AA, Gusmão RA, Goldsmith RS, Rezende JM, Rassi A: Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987, 155:561-564. This is the first paper to propose that anti-gp72 and anti-gp90 (as detected by RIPA) should be used as a supplemental test in order to confirm the existence of Trypanosoma cruzi antibodies.
78. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA: Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States: II. Evaluation of a supplemental enzyme immunoassay and radioimmuneprecipitation assay for confirmation of seroreactivity. Transfusion 1995, 35:219-225.
79. Leiby DA, Wendel S, Takaoka DT, Fachini R, Oliveira LC, Tibbals MA: Confirmatory testing for Trypanosoma cruzi antibodies: validation of radioimmuneprecipitation (RIPA) testing. Transfusion 1997, 37(suppl 9S):S301.